Document Detail


Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics.
MedLine Citation:
PMID:  16557674     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
The minimum inhibitory concentrations of penicillin and cephalothin necessary to inhibit growth of most anaerobic bacteria were reduced to a susceptible level by 1 to 5 mug of clavulanic acid per ml. In most cases, minimum inhibitory concentrations of cefoxitin were not affected.
Authors:
J Wüst; T D Wilkins
Related Documents :
11377374 - Polyunsaturated fatty acids, melatonin, and cancer prevention.
22262464 - The direct asymmetric α alkylation of ketones by brønsted acid catalysis.
16661774 - Mechanism of specific inhibition of phototropism by phenylacetic acid in corn seedling.
22179234 - Characteristics of spoilage-associated secondary cucumber fermentation.
1872874 - Evidence for isoleucine as a positive effector of the ilvbn operon in salmonella typhim...
25124514 - Sub-chronically exposing mice to a polycyclic aromatic hydrocarbon increases lipid accu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  13     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  1978 Jan 
Date Detail:
Created Date:  2010-06-25     Completed Date:  2010-06-25     Revised Date:  2010-09-14    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  130-3     Citation Subset:  -    
Affiliation:
Institute for Medical Microbiology, University of Zurich, CH-8028 Zurich, Switzerland .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experimental Urinary Tract Infection in Rats Caused by Candida albicans.
Next Document:  In Vitro and In Vivo Activity of a Synthetic Halogenated Quinoline Against Cryptococcus neoformans.